[VRTX] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
01-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -0.45%
YoY- 28.97%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 1,515,107 1,413,265 949,828 941,293 858,435 870,106 784,535 55.01%
PBT 657,534 676,950 70,666 327,138 320,165 32,497 136,511 184.93%
Tax 54,781 93,716 13,148 59,711 51,534 -1,492,599 8,055 258.53%
NP 602,753 583,234 57,518 267,427 268,631 1,550,527 128,746 179.59%
Tax Rate -8.33% -13.84% -18.61% -18.25% -16.10% 4,593.04% -5.90% -
Total Cost 912,354 830,031 892,310 673,866 589,804 -680,421 655,789 24.59%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 39.78 41.27 6.06 28.41 31.29 178.20 16.41 80.35%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS 2.32 2.26 0.22 1.04 1.05 6.08 0.51 174.29%
EPS Diluted 2.29 2.23 0.22 1.03 1.03 5.97 0.50 175.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.